OKLAHOMA CITY & MONTHEY, Switzerland--(BUSINESS WIRE)--ExcellGene SA, a leading Swiss biotech service provider specializing in mammalian cell line development for more than two decades, proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization (CDMO) based in the USA..

俄克拉何马城和瑞士蒙蒂——（商业新闻短讯）——瑞士领先的生物技术服务提供商ExcelGene SA，专注于哺乳动物细胞系开发超过二十年，骄傲地宣布与美国著名的合同开发和制造组织Cytovance Biologics进行战略合作。。

As CHO (Chinese Hamster Ovary) and HEK (Human Embryonic Kidney) cells are the most well-suited mammalian cell lines for recombinant protein production and biological research, this partnership represents a significant milestone in advancing biopharmaceutical development by providing ExcellGene’s pioneering transposon technologies to Cytovance’s biopharma customers..

由于CHO（中国仓鼠卵巢）和HEK（人类胚胎肾）细胞是最适合重组蛋白生产和生物学研究的哺乳动物细胞系，因此这种合作关系通过向Cytovance的生物制药客户提供ExcelGene开创性的转座子技术，代表了推进生物制药发展的重要里程碑。。

ExcellGene’s bespoke CHO and HEK cell lines can be used to optimize protein quality, quantity, development timelines, and scalability for biomanufacturing through custom engineering to the specific requirements of a protein. Combining these engineered cell lines with Cytovance’s cGMP manufacturing expertise, the companies expect to deliver a higher yield range of up to 10 g/L, empowering customers to rapidly advance their therapeutics from upstream development to clinical and commercial scale operations..

Excelgene的定制CHO和HEK细胞系可用于优化蛋白质质量，数量，开发时间表和生物制造的可扩展性，通过定制工程来满足蛋白质的特定要求。将这些工程细胞系与Cytovance的cGMP制造专业知识相结合，这些公司预计将提供高达10 g/L的更高产量范围，使客户能够将其治疗方法从上游开发快速推进到临床和商业规模运营。。

'We are thrilled to partner with Cytovance Biologics, a company that shares our commitment to excellence and innovation in biopharmaceutical manufacturing,” said Maria Wurm, CEO of ExcellGene SA. “Much like the team at Cytovance, I am proud to say that we have incredible experts in our company who are capable of mastering every challenge.

“我们很高兴与Cytovance Biologics合作，Cytovance Biologics是一家致力于生物制药制造业卓越和创新的公司，”ExcellGene SA首席执行官玛丽亚·沃尔姆（Maria Wurm）说。“与Cytovance的团队一样，我很自豪地说，我们公司拥有令人难以置信的专家，他们能够应对每一个挑战。

Our top priority is to provide seamless services and cost-effective solutions tailormade for our clients’ needs.'.

我们的首要任务是为客户的需求量身定制无缝服务和经济高效的解决方案。

Stephanie Wickham, PhD, Senior Director of Technology at Cytovance, shared that, “Coupling our organizations’ respective 50+ years of experience in delivering solutions to the industry, we are very much looking forward to shepherding critical proteins expressed in one of ExcellGene’s exceptional host cell lines through process development and eventually, into our 2000L tanks.

Cytovance高级技术总监Stephanie Wickham博士表示：“结合我们各组织在为行业提供解决方案方面50多年的经验，我们非常期待通过工艺开发，并最终将Excelgene一种特殊宿主细胞系中表达的关键蛋白导入我们的2000L储罐中。

This partnership is part of our intentional effort to expand our ‘best of breed’ network and build a robust selection of cell and strain options so that our clients can always find the perfect fit for their target protein.”.

这种合作关系是我们有意扩大“同类最佳”网络的一部分，并建立了强大的细胞和菌株选择，以便我们的客户总能找到最适合其目标蛋白质的产品。”。

Both organizations will be attending the BIO International Convention in San Diego and look forward to spotlighting the power of this partnership.

这两个组织都将参加在圣地亚哥举行的国际生物技术大会，并期待着彰显这种伙伴关系的力量。